<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iarjms</journal-id><journal-id journal-id-type="pubmed">IARJMS</journal-id><journal-id journal-id-type="publisher">IARJMS</journal-id><issn>2708-3594</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iarjms.2021.v02i01.085</article-id><title-group><article-title>Positive Clinical Impacts of Branched Chain Amino Acids Based Protein in Cachectic Hospitalized Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>SinanAhmad</given-names><surname>Badwan</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>MohammadSaid</given-names><surname>Alkader</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>YazanEmad</given-names><surname>Moumani</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>MaherNayef Bani</given-names><surname>Essa</surname></name></contrib><xref ref-type="aff" rid="aff-a" /></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>MuthafarMohammad</given-names><surname>Saleh</surname></name></contrib><xref ref-type="aff" rid="aff-b" /></contrib-group><aff-id id="aff-a">King Hussein Medical Hospital, Jordanian Royal Medical Services, Amman, Jordan</aff-id><aff-id id="aff-b">King Hussein Medical Hospital, King Abdullah II St 230, Amman 11733, Jordanian Royal Medical Services, Jordan</aff-id><abstract>Objectives: Cachexia is a dysregulation of fat, protein, and carbohydrate metabolism largely due to cytokine excess; ultimately resulting in severe wasting of the body’s lean body mass (LBM), albumin, and&amp;nbsp;branched-chain amino acids (BCAA) depletion. The aim of this study is to evaluate the clinical differences between two commercially available WP formulas that differ in BCAAs enrichment proportion.&amp;nbsp;Methods: A retrospective analysis was conducted in our institution between Jan 2019 and Jan 2021. Patient who had 2≤ episodes of diarrhea or failed to complete one week of hospital admission were excluded. All patients’ continuous variables were analyzed using Independent Samples and One-Sample T-test while categorical data were expressed as numbers with percentages by using Chi Square test.&amp;nbsp;Results: Group I (%BCAAs≥20%) demonstrated a significantly shorter length of stay (LOS) and lower overall 28-day mortality compared with Group II (%BCAAs≈12%) with Mean±SD of (9.80±1.79 days vs. 12.00±2.33 days) and Mean percentage of (20.97% vs. 13.33%), respectively. Percent changes in albumin level (%∆ALB) were significantly higher in Group I compared with Group II (35.3%±4.64% vs. 28.3%±5.49%). Conclusion:&amp;nbsp;BCAAs enriched WP formula was superior to standard WP formula in stimulating ALB synthesis and LBM anabolism/catabolism ratio in cachexic hospitalized hypoalbuminemic patients.&amp;nbsp;&amp;nbsp;</abstract></article-meta></front><body /><back /></article>